Navigation Links
Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis
Date:12/17/2008

ities Test and the Subject's Global Assessment), the significant memory findings coupled with an encouraging safety profile clearly define the drug's effects and differentiate it from d-amphetamine in clinically meaningful ways, Cognition Pharmaceuticals said. Continued analyses of study data in several domains is in process.

"We are extremely encouraged by very strong findings in the areas of verbal and visual memory and learning from our trial. These memory results are consistent with and fit well with our understanding of the mechanism of action of C105 as documented in a range of preclinical and clinical studies," according to Cognition Pharmaceuticals President and Chief Scientific Officer David Erlanger, Ph.D.

The potential for C105 to help human memory was first identified by a team of researchers led by Mark Bear, Ph.D., currently Director of the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology. "In animals, we discovered that C105 can modulate memory consolidation -- a biochemical process by which temporary or labile changes in synaptic function are made enduring. We believe that C105 augments the function of modulatory systems in the brain that normally control memory strength. It is very exciting to see that this insight may be of therapeutic significance in humans with memory disorders."

Analyses of the full dataset from the trial are ongoing, with Drs. Ralph Benedict and Frederick Munschauer of the Jacobs Neurological Institute in Buffalo, New York serving as Co-Principal Investigators. A series of discussions with leading medical experts and publication of more detailed results over the coming months are under way.

About the Study

The Phase 2 trial was conducted by Cognition Pharmaceuticals, which described it as a randomized, double-blind, placebo-controlled, dose-titration study. A total of 151 su
'/>"/>

SOURCE Cognition Pharmaceuticals LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Certified Nursing Assistants Receive Scholarships At Annual Recognition Program
2. Pink Power Moms Unite in Atlanta for Day of Pampering and Recognition
3. AssistNow Offers Area Employers Complimentary Needs Assessment in Recognition of National Drug-Free Work Week
4. Baylor Health Care System Receives National Information Technology Recognition
5. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
6. ABCs Bob Woodruff to Be Recognized at National Academy of Neuropsychology 1st Annual Public Awareness Recognition Ceremony
7. Diabetes America Physicians Achieve Industry Recognition for Quality Patient Care
8. Free Diabetes Eye Screenings Taking Place in Recognition of World Diabetes Day
9. Twins study shows genetic basis for face and place recognition
10. Leading National Patient Advocacy Group Commends Insurance Industrys Recognition, Focus on Growing National Problem of Uninsured and Underinsured Americans
11. Susan G. Komen for the Cures CEO Hala Moddelmog Earns High Heels in High Places Recognition at 2008 Trumpet Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 23, 2015 VogueQueen is a ... affordable prices and many designers are thrilled to have it ... business announces its new collection of prom dresses for the ... to drive the strategic vision and he focuses on continuing ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... a common side effect- cough. Iron supplementation cures the ... blood pressure medication. , The angiotensin-converting enzyme (ACE) inhibitors ... failure and other cardiac conditions. But up to 40% ... cough. The side effect is not considered serious by ...
... in Germany have developed a new risk assessment methodology ... patient's risk of cardiac death. , ECG is the ... can be determined and analysed by the computer.The time ... be calculated.// When the programme has completed its analysis, ...
... starch, previously thought to be just 'empty calories', actually helps ... Organisation (CSIRO), researchers have revealed that resistant starch could be ... , , ... China have low rates of bowel cancer even though they ...
... small amounts of alcohol consumption is linked with deliquent ... new study. ,Dr. Virginia Delaney-Black, of Children's Hospital ... out with the finding that in comparison to the ... a week during pregnancy were three times more likely ...
... slimming FDA approved drug which can actually works. Not only that ... slimming. This wonder slimming drug is XENICAL. ,Xenical allows ... pass through the gut undigested. Your body cannot convert these excess ... energy. This will therfore help you to reduce your weight, maintain ...
... biopsy detecting technique for prostate cancers has been found out ... traditional examination. In the traditional exam for prostate cancer, the ... , At Ohio State University, researchers said that it is ... team, called this the extended sector biopsy. They ...
Cached Medicine News:
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, ... Global Biotechnology, Inc. for the compounding, packaging and distributing of ... in the United States . ... capable of compounding naltrexone tablets in various strengths for individual ...
(Date:1/23/2015)... Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself ... share and grab a foothold in the hydroponic, hemp and ... and a presence in the sector, and recently partnering with ... of hemp and medical marijuana, iMD is committing to bring ...
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... Clinical Trials for Organ Transplantation, HORSHOLM, Denmark, May ... I clinical results for,its transplantation product candidate, LCP-Tacro ... organ transplantation. , Today LifeCycle Pharma A/S (OMX:LCP) ... program of LCP-Tacro, a,proprietary, once-daily tacrolimus tablet. , ...
... at the Pediatric Academic Societies' Annual Meeting,This Month ... Pulse,Oximetry Technology Can Reduce the Risk Associated with ... /PRNewswire/ -- Masimo, the,inventor of Pulse CO-Oximetry and ... a new independent study,presented at the Pediatric Academic ...
Cached Medicine Technology:LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 2Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 3Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 4
... 463 is a quality control material that, ... performance of blood gas, electrolyte, metabolite, and ... to the use of human blood in ... (3) levels for monitoring analyzer performance at ...
Molteno3 Glaucoma Drainage Device incorporates the latest advances from Professor Moltenos glaucoma research. It has been extensively tested since early 2004 and gives even better control of intraocu...
... way to capture and process ultrasound images, ... a revolutionary advancement. The z.one platform, powered ... Convertible Ultrasound system, instantly converting from a ... ultrasound system with all the performance of ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Medicine Products: